Park Ha Biological Technology is trading 7.26% down at $2.24 after a September 10, 2026 investor notice reiterated an existing securities class action and September 28 lead-plaintiff deadline.
- The lawsuit alleges misleading disclosures, a fraudulent stock-promotion scheme, and artificial trading activity involving the company’s shares.
- The release does not report a new filing or explicitly quantify its impact on the stock.